# EDGAR Filing Document

**Accession Number:** 0001811115
**File Stem:** 0001213900-25-069259
**Filing Date:** 2025-7
**Character Count:** 3151
**Document Hash:** 014db9bf07b82a4e3704559ce4f8c62f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-069259.hdr.sgml**: 20250730

**ACCESSION NUMBER**: 0001213900-25-069259

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250730

**DATE AS OF CHANGE**: 20250730

**EFFECTIVENESS DATE**: 20250730

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Renalytix plc
- **CENTRAL INDEX KEY:** 0001811115
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39387
- **FILM NUMBER:** 251166850

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** FINSGATE
- **STREET 2:** 5-7 CRANWOOD STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **BUSINESS PHONE:** 44 29 2071 0570

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** FINSGATE
- **STREET 2:** 5-7 CRANWOOD STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Renalytix AI plc
- **DATE OF NAME CHANGE:** 20200430

---

| |
|:---|
| **UNITED STATES** |
| **SECURITIES AND EXCHANGE COMMISSION**<br> **Washington, D.C. 20549** |

---

**FORM 15**

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER**

**SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION**

**OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934.**

Commission File Number 001-39387

---

| |
|:---|
| **Renalytix plc**<br>|
| (Exact name of registrant as specified in its charter) |

---

---

| |
|:---|
| **2 Leman Street, London E1W 9US, United Kingdom; Tel: +44 20 3139 2910**  |
| (Address,including zip code, and telephone number, including area code, of registrant's principal executive offices) |

---

---

| |
|:---|
| **American Depository Shares (each representing two shares of ordinary stock, nominal value £0.0025 per share)** <br>**Ordinary Shares, nominal value £0.0025 per share**<br>|
| (Title of each class of securities covered by this Form) |

---

<br> (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | ☒ |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | ☒ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☐ |
| Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date: <u>157</u> 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
| Date: July 30, 2025 | By: | /s/ James McCullough |
|  | Name: | James McCullough |
|  | Title: | Chief Executive Officer |

---